Turkey's Koç University presented a new research center that will work on vaccines and treatments for infectious diseases including for COVID-19, funded by commercial İşbank for an annual budget over five million Turkish Liras. The new center will also work on diagnosis and public health.
Turkish scientists have produced a domestic reproduction of Favipiravir, widely used to treat COVID-19. Industry and Technology Minister Mustafa Varank said that once the drug was registered and mass produced, it would also be exported.
Some 27 medical associations released an official statement that criticize recent regulation that mandates all COVID-19 research in Turkey receive approval from the Health Ministry. The organizations noted that ethics boards are responsible for evaluating research projects. Health Ministry approval will be required for projects that have ethics board approval, and those that are still pending approval.